PPT-Countries using and planning to introduce IPV

Countries using and planning to introduce IPV July 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV . Countries using and planning to introduce IPV. June 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Countries using and planning to introduce IPV. September 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Countries using and planning to introduce IPV. August 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . Countries using and planning to introduce IPV. March 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . bOPV. registration. Countries using and planning to introduce IPV. December 2015 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . planning to introduce IPV. and the global status of . bOPV. registration. Countries using and planning to introduce IPV. May 2016 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . planning to introduce IPV. and the global status of . bOPV. registration. Countries using and planning to introduce IPV. Novem. ber . 2016 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . and the global status of . bOPV. registration. Countries using and planning to introduce IPV. March 2016 April . 2016 status report. This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). . (. fIPV) . vaccine administration. Training for . the introduction of . Inactivated. . P. oliovirus . Vaccine, . Fractional. Dose (fIPV). Learning objectives. At the end of the module, the participant will be able to:. Rationale and Programmatic Implications for Objective 2 of The Polio Eradication and Endgame Strategic Plan. Immunization Systems Management Group (IMG). Version date: February 10, 2014. Glossary of terms & abbreviations. Rationale and Programmatic Implications for Objective 2 of The Polio Eradication and Endgame Strategic Plan. Immunization Systems Management Group (IMG). Version date: February 10, 2014. Glossary of terms & abbreviations. Comprehensive technical module. R. ationale for IPV introduction & OPV withdrawal in relation to Objective 2 of The Polio Eradication & Endgame Strategic Plan. Immunization Systems Management Group (IMG). Rationale and Programmatic Implications for Objective 2 of The Polio Eradication and Endgame Strategic Plan. Immunization Systems Management Group (IMG). 25 March 2014. . Glossary of terms & abbreviations. Linda Madigan Runlett. MST-IPV Pilot Highlights. 2014 – Talks began between DCF and Dr. Schaeffer & Dr. Swenson (model . developers of . MST-BSF) to develop a new innovative treatment model addressing families impacted by intimate partner violence. Initial white paper developed by Dr. Schaeffer & Dr. Swenson (October, 2014).